Nageshwar Budha
Natus (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, PI3K/AKT/mTOR signaling in cancer, CAR-T cell therapy research, Pharmacogenetics and Drug Metabolism, Lipoproteins and Cardiovascular Health
Most-Cited Works
- → Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis(2018)651 cited
- → Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH-Dependent Solubility the Achilles Heel of Targeted Therapy?(2012)326 cited
- → Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)(2012)247 cited
- → Prevalence of Acid-Reducing Agents (ARA) in Cancer Populations and ARA Drug–Drug Interaction Potential for Molecular Targeted Agents in Clinical Development(2013)186 cited
- → A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors(2016)167 cited
- → A microbiological assessment of novel nitrofuranylamides as anti-tuberculosis agents(2008)106 cited
- → A physiologically based pharmacokinetic (PBPK) approach to evaluate pharmacokinetics in patients with cancer(2012)105 cited
- → A tandem mass spectrometry assay for the simultaneous determination of acetaminophen, caffeine, phenytoin, ranitidine, and theophylline in small volume pediatric plasma specimens(2008)100 cited
- → Discovery of novel isoxazolines as anti-tuberculosis agents(2007)93 cited
- → Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development(2021)70 cited